Indaptus Therapeutics, Inc. - Common Stock (INDP)

CUSIP: 45339J105

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
111,087,302
Total 13F shares
541,295
Share change
+541,295
Total reported value
$4,239,000
Price per share
$7.83
Number of holders
9
Value change
+$4,239,000
Number of buys
9

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INDP - Indaptus Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Hoonmo Lee
3/4/5
Director
mixed-class rows
708,272
mixed-class rows
$1,626,157 04 Aug 2021

Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock (INDP) as of Q3 2021

As of 30 Sep 2021, Indaptus Therapeutics, Inc. - Common Stock (INDP) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 541,295 shares. The largest 9 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, INVESTMENT HOUSE LLC, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, Harel Insurance Investments & Financial Services Ltd., MORGAN STANLEY, and UBS Group AG. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q1 2025 Across Filers

Q1 2025 holders
17
Q3 2021 holders
9
Holder diff
-8
Investor Q1 2025 Shares Q3 2021 Shares Share Diff Share Chg % Q1 2025 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.